Higher baseline PD-L1 combined positive score (CPS) and pre- and on-treatment stromal tumor-infiltrating lymphocytes were significantly associated with higher pCR rates (P = 0.0127, 0.0059, and 0.0085, respectively) [13]. This evidence concerns the gene CD274 and neoplasm.